Modelling the optimal target age group for seasonal influenza vaccination in Japan

Vaccine. 2020 Jan 22;38(4):752-762. doi: 10.1016/j.vaccine.2019.11.001. Epub 2019 Nov 15.

Abstract

Background: In Japan, the current influenza vaccination programme is targeting older individuals. On the other hand, epidemics of influenza are likely to be mainly driven by children. In this study, we consider the most cost-effective target age group for a seasonal influenza vaccination programme in Japan.

Methods: We constructed a deterministic compartmental Susceptible-Exposed-Infectious-Recovered (SEIR) model with data from the 2012/13 to 2014/15 influenza seasons in Japan. Bayesian inference with Markov Chain Monte Carlo method was used for parameter estimation. Cost-effectiveness analyses were conducted from public health care payer's perspective.

Results: A scenario targeting children under 15 was expected to reduce the number of cases 6,382,345 compared to the current strategy. A scenario targeting elderly population (age over 49 years) was expected to reduce the number of cases 693,206. The children targeted scenario demonstrated negative ICER (incremental cost-effectiveness ratio) value. On the other hand, elderly targeted scenario demonstrated higher ICER value than the willingness to pay (50,000 USD/QALY).

Conclusions: A vaccination programme which targets children under 15 is predicted to have much larger epidemiological impact than those targeting elderly.

Keywords: Cost-effectiveness analysis; Influenza; Japan; Mathematical model; Vaccination policy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Child
  • Child, Preschool
  • Cost-Benefit Analysis
  • Humans
  • Immunization Programs*
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / economics
  • Influenza, Human / economics
  • Influenza, Human / prevention & control*
  • Japan
  • Middle Aged
  • Models, Theoretical
  • Monte Carlo Method
  • Seasons
  • Vaccination / economics
  • Vaccination / methods*
  • Young Adult

Substances

  • Influenza Vaccines